Détail de l'auteur
Auteur C. ACEIJAS
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3by5') / C. ACEIJAS
Titre : Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3by5') Titre traduit : (Le traitement antirétroviral chez les usagers de drogues par injection dans les pays en cours ou en voie de développement un an avant le terme du programme de l'OMS "traiter 3 million de personnes d'ici 2005. Tout faire pour que cela arrive" Type de document : Périodique Auteurs : C. ACEIJAS ; E. OPPENHEIMER ; G. V. STIMSON ; R. E. ASHCRAFT ; S. MATIC ; M. HICKMAN Année de publication : 2006 Importance : 1246-1253 Présentation : tabl. Note générale : Addiction, 2006, 101, (9), 1246-1253 Langues : Anglais (eng) Mots-clés : Thésaurus Géographique
EUROPE ; AMERIQUE DU SUD ; ASIE ; AFRIQUE
VIH ; ANTIVIRAUX ; INJECTION ; TRAITEMENT ; PREVALENCE ; PROGRAMME ; EFFICACITE
Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : Objective: To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries. Methods: Literature review of grey and published literature and key informants' communications on the estimated number of current/former injecting drug users (IDUs) receiving ART and the proportion of human immunodeficiency virus (HIV) attributed to injecting drug use (IDU), the number of people in ART and in need of ART, the number of people living with HIV/acquired immunodeficiency syndrome (AIDS) (PLWHA) and the main source of ART. Results: Data on former/current IDUs on ART were available from 50 countries (in 19 countries: nil IDUs in treatment) suggesting that ~34 000 IDUs were receiving ART by the end of 2004, of whom 30 000 were in Brazil. In these 50 countries IDUs represent ~15% of the people in ART. In Eastern European and Central Asia IDU are associated with > 80% of HIV cases but only ~ 2000 (14%) of the people in ART. In South and South-East Asia there were ~1700 former/current IDUs receiving ART ~1.8% of the people in ART), whereas the proportion of HIV cases associated to IDU is > 20% in five countries (and regionally ranges from 4% to 75%). Discussion: There is evidence that the coverage of ART among current/former IDUs is proportionally substantially less than other exposure categories. Ongoing monitoring of ART by exposure and population subgroups is critical to ensuring that scale-up is equitable, and that the distribution of ART is, at the very least, transparent. (Author' s abstract) Domaine : Drogues illicites / Illicit drugs Refs biblio. : 34 Affiliation : Centre for Research on Drugs and Health Behaviour (CRDHB), Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London WCIE 7HT, Royaume-Uni. United Kingdom. Numéro Toxibase : 208860 Centre Emetteur : 02 Coordonnateur Permalink : Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution / C. ACEIJAS
Titre : Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution Titre traduit : (Estimations des usagers par injection et de leur distribution par sexe et par âge, aux niveaux national et local dans des pays en développement et en transition) Type de document : Périodique Auteurs : C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN Année de publication : 2006 Importance : iii10-iii17 + tabl. Présentation : tabl. Note générale : Sexually Trasmitted Infections, 2006, 82, (Suppl.III), iii10-iii17 + tabl.
Erratum in: Sex Transm Infect. 2006 Aug;82(4):344.
Langues : Français (fre) Mots-clés : Thésaurus TOXIBASE
DEVELOPPEMENT ; EVALUATION ; ETUDE PROSPECTIVE ; INJECTION ; PREVALENCE ; SEXE ; AGE ; PRODUIT ILLICITE
EUROPE DE L'EST ; INTERNATIONAL ; ASIE ; AFRIQUE ; AMERIQUE DU SUD
Discipline : EPI Epidémiologie / Epidemiology Résumé :
OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature review of both grey and published literature including updates from previously reported estimates on estimates of IDU population and data sources giving age and gender breakdowns. The scope area was developing/transitional countries and the reference period was 1998-2005. RESULTS: Estimates of IDU numbers were available in 105 countries and 243 subnational areas. The largest IDU populations were reported from Brazil, China, India, and Russia (0.8 m, 1.9 m, 1.1 m, and 1.6 m respectively). Subnational areas with the largest IDU populations (35,000-79,000) are: Warsaw (Poland); Barnadul, Irtkustk, Nizhny-Novgorod, Penza, Voronez, St Petersburg, and Volgograd (Russia); New Delhi and Mumbai (India); Jakarta (Indonesia), and Bangkok (Thailand). By region, Eastern Europe and Central Asia have the largest IDU prevalence (median 0.65%) (min 0.3%; max 2.2%; Q1 0.39%; Q3 1.32%) [corrected] followed by Asia and Pacific: 0.24% (min 0.004%; max 1.47%; Q1 0.14%; Q3 1.47%) [corrected] In the Middle East and Africa the median value equals 0.2% (min 0.0003%; max 0.35%; Q1 0.11%; Q3 0.23%) [corrected] and in Latin America and the Caribbean: 0.12% (min 0.11%; max 0.69%; Q1 0.04%; Q3 0.13%) [corrected] Subnational areas with the highest IDU prevalence among adults (8-14.9%) were Shymkent (Kazakhstan), Balti (Moldova), Astrakhan, Barnadul, Irtkustk, Khabarovsk, Kaliningrad, Naberezhnyje Chelny, Penza, Togliatti, Volgograd, Voronez, and Yaroslavl (Russia), Dushanbe (Tajikistan), Ashgabad (Turkmenistan), Ivano-Frankivsk and Pavlograd (Ukraine) and Imphal, Manipur (India). 66% (297/447) of the IDU estimates were reported without technical information. Data on the IDU age/gender distributions are also scarce or unavailable for many countries. In 11 Eastern European and Central Asian countries the age group 50% of the total. The proportion of IDU men was 70%-90% in Eastern Europe and Central Asia, and there was a marked absence of data on women outside this region. CONCLUSION: Unfortunately data on IDU prevalence available to national and international policymakers is of an unknown and probably yet to be tested quality. This study provide baseline figures but steps need to be taken now to improve the reporting and assessment of these critical data.
Note de contenu : tabl. Domaine : Drogues illicites / Illicit drugs Sous-type de document : Revue de la littérature / Literature review Refs biblio. : 42 Affiliation : Department of Public Health and Policy, Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT. Email : Carmen.Aceijas@lshtm.ac.uk
Royaume-Uni. United Kingdom.
Numéro Toxibase : 1301832 Centre Emetteur : 13 OFDT Cote : A02905 Permalink : Global overview of injecting drug use and HIV infection among injecting drug users / C. ACEIJAS
Titre : Global overview of injecting drug use and HIV infection among injecting drug users Titre traduit : (Une vue globale de l'usage de drogues par injection et de l'infection VIH parmi les usagers de drogues injectables.) Type de document : Périodique Auteurs : C. ACEIJAS ; G. V. STIMSON ; M. HICKMAN ; T. RHODES Année de publication : 2004 Importance : 2295-2303 Présentation : tabl. Note générale : AIDS, 2004, 18, (17), 2295-2303 Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
USAGER ; INJECTION ; PREVALENCE ; VIH
EUROPE ; ASIE ; AMERIQUE DU SUD ; CARAIBES ; AMERIQUE DU NORD ; AFRIQUE
Discipline : EPI Epidémiologie / Epidemiology Résumé :
Objective: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries. Methods: Collation and review of existing estimates of IDU prevalence and HIV prevalence from published and unpublished documents for the period 1998-2003. The strength of evidence for the information was assessed based on the source and type of study. Results: Estimates of IDU prevalence were available for 130 countries. The number of IDU worldwide was estimated as approximately 13.2 million. Over ten million (78%) live in developing and transitional countries (Eastern Europe and Central Asia, 3.1 million; South and South-east Asia, 3.3 million; East-Asia and Pacific, 2.3 million). Estimates of HIV prevalence were available for 78 countries. HIV prevalence among IDU of over 20% was reported for at least one site in 25 countries and territories: Belarus, Estonia, Kazakhstan, Russia, Ukraine, Italy, Netherlands, Portugal, Serbia and Montenegro, Spain, Libya, India, Indonesia, Malaysia, Myanmar, Nepal, Thailand, Viet Nam, China, Argentina, Brazil, Uruguay, Puerto Rico, USA and Canada. Conclusions: These findings update previous assessments of the number of countries with IDU and HIV-infected IDU, and the previous quantitative global estimates of the prevalence of IDU. However, gaps remain in the information and the strength of the evidence often was weak. (Author' s abstract)
Note de contenu : tabl. Domaine : Drogues illicites / Illicit drugs Affiliation : Centre for Research on Drugs and Health Behaviour, Imperial College, Fac. Medicine, St Dunstan's Road, London, W6 8RP
Royaume-Uni. United Kingdom.
Numéro Toxibase : 208159 Centre Emetteur : 02 Coordonnateur Permalink :